StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics profit margin

Profit margin (net margin) is net income as a percentage of revenue.

For fiscal 2025 it was -3509.7%.

Annual profit margin

PeriodPeriod endValueChange (pts)
FY2025Dec 31, 2025-3509.7%–

Quarterly profit margin

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange (pts)
Q1 FY2026Mar 31, 2026-11000.0%–

More Allarity Therapeutics figures

See a number that looks wrong?